{"DataElement":{"publicId":"3431712","version":"1","preferredName":"Soft Tissue Sarcoma Cancer American Joint Committee on Cancer (AJCC) Edition 7 Pathologic Regional Lymph Node N Stage","preferredDefinition":"Extent of the regional lymph node involvement for the soft tissue sarcoma based on evidence obtained from pathologic examination through completion of definitive surgery.","longName":"2197710v1.0:3431389v1.0","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"2197710","version":"1","preferredName":"Sarcoma Pathologic N Stage","preferredDefinition":"information related to the pathologic N stage of a sarcoma.","longName":"SARCOMA_P_N","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2177012","version":"1","preferredName":"Sarcoma","preferredDefinition":"A usually aggressive malignant mesenchymal cell tumor most commonly arising from muscle, fat, fibrous tissue, bone, cartilage, and blood vessels.  Sarcomas occur in both children and adults.  The prognosis depends largely on the degree of differentiation (grade) of the tumor.  Representative subtypes are liposarcoma, leiomyosarcoma, osteosarcoma, and chondrosarcoma. -- 2004","longName":"Sarcoma","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Sarcoma","conceptCode":"C9118","definition":"A usually aggressive malignant neoplasm of the soft tissue or bone. It arises from muscle, fat, fibrous tissue, bone, cartilage, and blood vessels. Sarcomas occur in both children and adults. The prognosis depends largely on the degree of differentiation (grade) of the neoplasm. Representative subtypes are liposarcoma, leiomyosarcoma, osteosarcoma, and chondrosarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACAAECCE-7AD9-657B-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2428379","version":"1","preferredName":"Pathologic N Stage","preferredDefinition":"Pathologic; caused by or altered by or manifesting disease or pathology.:One criteria of the TMN staging system. N refers to the extent of lymph node involvement.","longName":"C25610:C25580","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"N Category","conceptCode":"C25580","definition":"One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"053C2A34-084E-693F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-11","modifiedBy":"ONEDATA","dateModified":"2005-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EEFC4E03-AC2F-6E32-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-01-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-01-31","modifiedBy":"TAYLORT","dateModified":"2019-03-29","changeDescription":"3-29-19 Received permission from Brian Campbell to transfer DEC ownership from CTEP to NCI Standards; tmt.  Updated to use Property based on NCIt concepts","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3431389","version":"1","preferredName":"Soft Tissue Sarcoma American Joint Committee on Cancer (AJCC) Edition 7 N Stage","preferredDefinition":"A finding about one or more characteristics of soft tissue sarcoma, following the rules of the TNM AJCC v7 classification system.  Kaposi sarcoma, fibromatosis (desmoid tumor), and sarcoma arising from the dura mater, brain, parenchymatous organs, or hollow viscera are not included in this classification. (from AJCC 7th Ed.)_A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._One criteria of the TNM staging system. N refers to the extent of lymph node involvement._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"3431389v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"2","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"N0","valueDescription":"Soft Tissue Sarcoma pN0 TNM Finding v7","ValueMeaning":{"publicId":"3431414","version":"1","preferredName":"Soft Tissue Sarcoma pN0 TNM Finding v7","longName":"3431414","preferredDefinition":"Soft tissue sarcoma without regional lymph node metastasis. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Soft Tissue Sarcoma pN0 TNM Finding v7","conceptCode":"C88462","definition":"Soft tissue sarcoma without regional lymph node metastasis. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCE113ED-7038-96BE-E040-BB89AD435DF2","latestVersionIndicator":"Yes","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"ONEDATA","dateModified":"2012-04-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BCE113ED-7051-96BE-E040-BB89AD435DF2","beginDate":"2010-06-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"ONEDATA","dateModified":"2012-04-04","deletedIndicator":"No"},{"value":"N1","valueDescription":"Soft Tissue Sarcoma pN1 TNM Finding v7","ValueMeaning":{"publicId":"3431416","version":"1","preferredName":"Soft Tissue Sarcoma pN1 TNM Finding v7","longName":"3431416","preferredDefinition":"Soft tissue sarcoma with regional lymph node metastasis.  Note: Presence of positive nodes (N1) in M0 tumors is considered Stage III. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Soft Tissue Sarcoma pN1 TNM Finding v7","conceptCode":"C88463","definition":"Soft tissue sarcoma with regional lymph node metastasis.  Note: Presence of positive nodes (N1) in M0 tumors is considered Stage III. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCE113ED-705E-96BE-E040-BB89AD435DF2","latestVersionIndicator":"Yes","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BCE113ED-7077-96BE-E040-BB89AD435DF2","beginDate":"2010-06-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"ONEDATA","dateModified":"2012-04-04","deletedIndicator":"No"},{"value":"NX","valueDescription":"Soft Tissue Sarcoma pNX TNM Finding v7","ValueMeaning":{"publicId":"3431418","version":"1","preferredName":"Soft Tissue Sarcoma pNX TNM Finding v7","longName":"3431418","preferredDefinition":"Soft tissue sarcoma in which regional lymph nodes cannot be assessed.  (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Soft Tissue Sarcoma pNX TNM Finding v7","conceptCode":"C88461","definition":"Soft tissue sarcoma in which regional lymph nodes cannot be assessed.  (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCE113ED-7084-96BE-E040-BB89AD435DF2","latestVersionIndicator":"Yes","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"ONEDATA","dateModified":"2012-04-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BCE113ED-709D-96BE-E040-BB89AD435DF2","beginDate":"2010-06-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"ONEDATA","dateModified":"2012-04-04","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3431388","version":"1","preferredName":"Soft Tissue Sarcoma TNM Finding v7 American Joint Committee on Cancer N Stage Stage","preferredDefinition":"A finding about one or more characteristics of soft tissue sarcoma, following the rules of the TNM AJCC v7 classification system.  Kaposi sarcoma, fibromatosis (desmoid tumor), and sarcoma arising from the dura mater, brain, parenchymatous organs, or hollow viscera are not included in this classification. (from AJCC 7th Ed.):A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:One criteria of the TNM staging system. N refers to the extent of lymph node involvement.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C88449:C39315:C25580:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Soft Tissue Sarcoma TNM Finding v7","conceptCode":"C88449","definition":"A finding about one or more characteristics of soft tissue sarcoma, following the rules of the TNM AJCC v7 classification system.  Kaposi sarcoma, fibromatosis (desmoid tumor), and sarcoma arising from the dura mater, brain, parenchymatous organs, or hollow viscera are not included in this classification. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"N Category","conceptCode":"C25580","definition":"One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCE08C3B-8361-97DD-E040-BB89AD4320D6","latestVersionIndicator":"Yes","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"ONEDATA","dateModified":"2012-04-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC:American Joint Committee on Cancer Cancer Staging Manual, 7th Ed., 2009","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCE08C3B-8372-97DD-E040-BB89AD4320D6","latestVersionIndicator":"Yes","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"COOPERM","dateModified":"2012-05-07","changeDescription":"Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3434437","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCIP"},{"publicId":"3434442","version":"1","longName":"Soft Tissue Sarcoma","context":"NCIP"}]},{"publicId":"3461150","version":"1","longName":"Staging","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461151","version":"1","longName":"AJCC Edition 7","context":"NCIP"}]},{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000596","version":"1","longName":"AJCC Edition 7","context":"NCI Standards"},{"publicId":"10000420","version":"1","longName":"Soft Tissue Sarcoma","context":"NCI Standards"}]},{"publicId":"5635300","version":"1","longName":"Case Report Form (CRF) Modules","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000689","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCI Standards"},{"publicId":"10000595","version":"1","longName":"AJCC Edition 7","context":"NCI Standards"}]}],"AlternateNames":[{"name":"LCC","type":"USED_BY","context":"LCC"},{"name":"AECC","type":"USED_BY","context":"AECC"},{"name":"CITN","type":"USED_BY","context":"CITN"},{"name":"PBTC","type":"USED_BY","context":"PBTC"},{"name":"OHSU Knight","type":"USED_BY","context":"OHSU Knight"},{"name":"NCIP","type":"USED_BY","context":"NCIP"},{"name":"STS_AJCC7_PATH_N_STG","type":"Context Short Name","context":"NCIP"}],"ReferenceDocuments":[{"name":"Pathologic N Stage","type":"Preferred Question Text","description":"Pathologic N Stage","url":null,"context":"NCI Standards"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Preferred Standard","id":"BCE48D59-B5ED-1F93-E040-BB89AD437852","latestVersionIndicator":"Yes","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"HARTLEYG","dateModified":"2021-06-17","changeDescription":"Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}